Abstract
Current prognostication of gastrointestinal stromal tumours is validated on/applies to resected tumours, mainly because surgery is recommended whenever possible. However, pre-treatment prognostication is increasingly warranted, considering the follow-up strategy recently admitted for expectedly low-risk tumours and the possible distinctive molecular features/spontaneous regression of some small cases.
Lingua originale | English |
---|---|
pagine (da-a) | 291-295 |
Numero di pagine | 5 |
Rivista | Digestive and Liver Disease |
Volume | 47 |
DOI | |
Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- Biopsy
- Gastrointestinal stromal tumour
- Prognosis
- Proliferation